Company Active LTD

Company profile

Multus Biotechnology Limited

Home | Multus Biotechnology - Key ingredients for the affordable scale-up of cellular agriculture

Key ingredients for the affordable scale-up of cellular agriculture

CRN
12524885
Founded
2020
Age
6

Overview

Legal name
MULTUS BIOTECHNOLOGY LIMITED
Region
Unknown
Registered address
TRANSLATION AND INNOVATION HUB
84 WOOD LANE
LONDON
UNITED KINGDOM
W12 0BZ
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
19

Company events

Reference milestones and recent Companies House filing stream events.

12 events
04 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

02 Jul
2026

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzUzMDAzODIyOWFkaXF6a2N4

Published 02 Jul 2026 09:23

21 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

15 Apr
2026

Replacement Filing Of Director Appointment With Name

Officers

RP01AP01 | Transaction MzUxNjQyMTYyMGFkaXF6a2N4 | Paper/PDF filed

Published 17 Apr 2026 01:11

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

01 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MTc3MDU3MmFkaXF6a2N4

Published 01 Nov 2024 03:56

03 Sep
2024

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQzNDExNjg4OWFkaXF6a2N4 | Paper/PDF filed

Published 04 Sep 2024 06:57

02 Sep
2024

Resolution

Resolution

RESOLUTIONS | Transaction QURBSDNGN1VhZGlxemtjeA | Paper/PDF filed

Published 03 Sep 2024 07:00

02 Sep
2024

Capital Name Of Class Of Shares

Capital

SH08 | Transaction MzQzNDExNjg4OGFkaXF6a2N4 | Paper/PDF filed

Published 03 Sep 2024 07:00

02 Sep
2024

Capital Variation Of Rights Attached To Shares

Capital

SH10 | Transaction MzQzNDExNjg4N2FkaXF6a2N4 | Paper/PDF filed

Published 03 Sep 2024 07:00

18 Mar
2020

Incorporated

Inception

Company registered at Companies House

Public funding

9 awards
First funded
2021
Funded years
2021, 2023, 2024, 2025
Age at first award
0 years

Projects

2025 Collaborative R&D Lead participant

FATSCAN - Fluorescence-based Adipo Tracking Screening for Cell Nutrition

1 Jul 2025 to 30 Sep 2026

Awarded
£244,662
Total cost £349,517

Multus Biotechnology and the Roslin Institute are embarking on a groundbreaking project to achieve high productivity and functionality in resource-efficient biomanufacturing. By leveraging a combination of cutting-edge approaches for stem cell analyses developed at Roslin, together with Multus' MediOP/Machine Learning platform for iterative media formulat...

2025 Collaborative R&D

CultLeather: Scaled Production of Lab Grown Leather

1 Jun 2025 to 31 May 2026

Awarded
£138,438
Total cost £197,769

This project pioneers a sustainable and cruelty-free approach to leather production by integrating cutting-edge biotechnology, advanced cell culture techniques, and scalable manufacturing processes. Traditional leather manufacturing relies heavily on cattle ranching, contributing to significant environmental challenges such as greenhouse gas emissions, de...

2024 Collaborative R&D

Towards Commercial Protein Production through Co-Engineering Marine Microorganisms and Feedstocks for Precision Fermentation

1 Apr 2024 to 31 Jan 2025

Awarded
£72,426
Total cost £103,466

We are redesigning precision fermentation to enable truly-scalable animal-free food production. Unsustainable agriculture and livestock industry are among the key drivers of GHG emissions, land use change and water use. To fight against environmental degradation, the food industry has been looking at innovative technologies to produce animal-free proteins...

2024 Collaborative R&D Lead participant

PRIME - Protein Recombination Improvement through Multidisciplinary Engineering

1 Feb 2024 to 31 Jan 2025

Awarded
£242,532
Total cost £346,475

Addressing the urgent need to sustainably feed our growing global population, Multus is committed to fostering resilient food supply chains that minimise adverse impacts on humans, the environment, and climate. Our focus lies on cultivated meat, a viable alternative to industrial meat production that significantly reduces antibiotic usage, land and water ...

2023 Collaborative R&D

Biomanufacturing downstream process optimisation and scaling with in-silico experimentation

1 Dec 2023 to 31 Dec 2024

Awarded
£89,651
Total cost £128,073

New Wave Biotech (NWB) is developing software that uses computational modelling to optimise downstream processes (DSP) for biomanufacturing, accelerating R&D and reducing final production costs of alternative proteins and other synthetic biology products. This solution transforms how DSP optimisation and scaling is done -- moving it from a slow, expensive...

2023 Collaborative R&D Lead participant

Standardising food safety testing for the cultivated meat industry: feasibility study to accelerate innovation

1 Nov 2023 to 31 Oct 2024

Awarded
£158,552
Total cost £226,503

With the global population projected to approach 10 billion by 2050, the demand for food is increasing. Alternative protein sources, including cultivated meat and seafood, can play a critical role in meeting this demand while reducing the environmental impact of intensive animal agriculture. Multus is a leader in the development of animal-free culture med...

2023 Collaborative R&D

CULT-GRO: A game-changing growth enhancer to accelerate the affordable scale-up of cultivated meat

1 Oct 2023 to 31 Mar 2025

Awarded
£280,102
Total cost £400,146

Rising meat/protein demand and awareness for environmental protection needs are driving changed outlooks within the meat industry. The growing need for alternative protein sources to combat meat shortages along with a fast-growing population is enhancing the need for cultured meat production. However, persistent technical challenges in manufacturing and i...

2023 EU-Funded Lead participant

Enabling affordable and sustainable cultivated meat with a first-in-class growth medium.

1 Jan 2023 to 31 Dec 2024

Awarded
£2,152,612
Total cost £3,075,160

no public description

2021 Collaborative R&D Lead participant

Proliferum M: Reinventing growth media for the cultivated meat industry.

1 Jan 2021 to 31 Mar 2021

Awarded
£112,033
Total cost £140,041

Current animal agriculture is highly unsustainable, it is one of the biggest contributors to climate change and has a significant resource uptake. Furthermore, global meat demand continues to increase at 3% per year. Current methods of meat production must be changed in order to prevent the impending global food crisis and hinder the further progression o...

Product types

Collaborative R&D EU-Funded